[HTML][HTML] Soluble guanylyl cyclase: A novel target for the treatment of vascular cognitive impairment?

E Nelissen, M Schepers, L Ponsaerts… - Pharmacological …, 2023‏ - Elsevier
Vascular cognitive impairment (VCI) describes neurodegenerative disorders characterized
by a vascular component. Pathologically, it involves decreased cerebral blood flow (CBF) …

Neuromodulatory effect of vardenafil on aluminium chloride/d-galactose induced Alzheimer's disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 pathway …

HH Awad, MA Desouky, A Zidan, M Bassem… - …, 2023‏ - Springer
Dysregulation of protein homeostasis, proteostasis, is a distinctive hallmark of many
neurodegenerative disorders and aging. Deleteriously, the accumulation of aberrant …

The 10th International Conference on cGMP 2022: recent trends in cGMP research and development—meeting report

A Friebe, JR Kraehling, M Russwurm… - Naunyn-schmiedeberg's …, 2023‏ - Springer
Increasing cGMP is a unique therapeutic principle, and drugs inhibiting cGMP-degrading
enzymes or stimulating cGMP production are approved for the treatment of various diseases …

BK channels sustain neuronal Ca2+ oscillations to support hippocampal long-term potentiation and memory formation

T Pham, T Hussein, D Calis, H Bischof… - Cellular and Molecular …, 2023‏ - Springer
Mutations of large conductance Ca2+-and voltage-activated K+ channels (BK) are
associated with cognitive impairment. Here we report that CA1 pyramidal neuron-specific …

Vericiguat preserved cardiac function and mitochondrial quality in a rat model of mitral regurgitation

P Jungtanasomboon, S Nussaro, H Winwan… - Life Sciences, 2023‏ - Elsevier
Aims New drugs for heart failure (HF) that target restoring the impaired NO-sGC-cGMP
pathway are being developed. We aimed to investigate the effects of vericiguat, an sGC …

The sGC stimulator BAY-747 and activator runcaciguat can enhance memory in vivo via differential hippocampal plasticity mechanisms

E Nelissen, N Possemis, NP Van Goethem… - Scientific reports, 2022‏ - nature.com
Soluble guanylate cyclase (sGC) requires a heme-group bound in order to produce cGMP, a
second messenger involved in memory formation, while heme-free sGC is inactive. Two …

[HTML][HTML] sGC agonist BAY1021189 promotes thoracic aortic dissection formation by accelerating vascular smooth muscle cell phenotype switch

H Jiang, Y Jiang, Y Qu, J Lv, H Zeng - European Journal of Pharmacology, 2023‏ - Elsevier
Thoracic aortic dissection (TAD) is common but lethal cardiovascular disease with high
mortality. This study aimed to expound whether and how sGC-PRKG1 signaling pathway …

Novel Insights into Changes in Gene Expression within the Hypothalamus in Two Asthma Mouse Models: A Transcriptomic Lung–Brain Axis Study

EM Bastawy, IM Eraslan, L Voglsanger… - International …, 2024‏ - pmc.ncbi.nlm.nih.gov
Patients with asthma experience elevated rates of mental illness. However, the molecular
links underlying such lung–brain crosstalk remain ambiguous. Hypothalamic dysfunction is …

Impact of vericiguat on baroreflex-mediated sympathetic circulatory regulation: an open-loop analysis

A Yokoi, T Kawada, S Yokota, M Kakuuchi… - Plos one, 2023‏ - journals.plos.org
Aims To quantify in vivo the effects of the soluble guanylate cyclase (sGC) stimulator,
vericiguat, on autonomic cardiovascular regulation in comparison with the nitric oxide (NO) …

Acute deletion of the central MR/GR steroid receptor correlates with changes in LTP, auditory neural gain, and GC-A cGMP signaling

D Calis, M Hess, P Marchetta, W Singer… - Frontiers in molecular …, 2023‏ - frontiersin.org
The complex mechanism by which stress can affect sensory processes such as hearing is
still poorly understood. In a previous study, the mineralocorticoid (MR) and/or glucocorticoid …